Literature DB >> 23573328

Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.

Xiaoxiao Xu1, Le Zhang, Yafei Wang, Qing Zhang, Lianyu Zhang, Baocun Sun, Yizhuo Zhang.   

Abstract

Double-hit or triple-hit B-cell lymphomas (DHL and THL) are rare subtype lymphomas usually associated with poor prognosis. It is defined by two or three recurrent chromosome translocations; MYC/8q24 loci, usually in combination with the t (14; 18) (q32; q21) bcl-2 gene or/and BCL6/3q27 chromosomal translocation. DHL was often observed both in de-novo diffuse large B cell lymphomas (DLBCL). It is otherwise unclassifiable, showing features intermediate that of large B-cell lymphoma and Burkitt lymphoma. Here, we present two follicular lymphoma patients; one transformed to THL, another transformed to DHL. Both cases revealed aggressive clinical courses with poor prognosis and associated with acquisition of c-Myc gene (MYC) and central nervous system (CNS) involvement. We reviewed the related literature, correlated the immunophenotype and clinical manifestations such as response to therapy and prognosis. Although the incidence of DHT and THL is low, cytogenetic and FISH analyses should be included when B-cell lymphoma patients experience relapse or refractory course of disease. We concluded that c-Myc may contribute to aggressive transformation, and more mechanism-based therapy should be explored.

Entities:  

Keywords:  BCL2; BCL6; Double hit; MYC; cases report; follicular lymphoma

Mesh:

Substances:

Year:  2013        PMID: 23573328      PMCID: PMC3606871     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation.

Authors:  N Macpherson; D Lesack; R Klasa; D Horsman; J M Connors; M Barnett; R D Gascoyne
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

2.  Progression of double-hit lymphoma in the midst of R-hyper CVAD.

Authors:  Javier Munoz; Mona Vekaria; Amr Hanbali; Nalini Janakiraman
Journal:  Am J Hematol       Date:  2012-04-10       Impact factor: 10.047

3.  High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis.

Authors:  Pei Lin; L Jeffrey Medeiros
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

4.  C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator?

Authors:  Lesley Christie; Neil Kernohan; David Levison; Mark Sales; Joan Cunningham; Karen Gillespie; Paul Batstone; David Meiklejohn; John Goodlad
Journal:  Leuk Lymphoma       Date:  2008-03

5.  Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas.

Authors:  W Y Au; R D Gascoyne; D S Viswanatha; B F Skinnider; J M Connors; R J Klasa; D E Horsman
Journal:  Br J Haematol       Date:  1999-05       Impact factor: 6.998

6.  The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.

Authors:  M C Marin; B Hsu; L C Stephens; S Brisbay; T J McDonnell
Journal:  Exp Cell Res       Date:  1995-04       Impact factor: 3.905

7.  The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.

Authors:  Steven Le Gouill; Pascaline Talmant; Cyrille Touzeau; Anne Moreau; Richard Garand; Nadine Juge-Morineau; Fanny Gaillard; Thomas Gastinne; Noël Milpied; Philippe Moreau; Jean Luc Harousseau; Hervé Avet-Loiseau
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

8.  Involvement of the bcl-2 gene in human follicular lymphoma.

Authors:  Y Tsujimoto; J Cossman; E Jaffe; C M Croce
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728

9.  Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Authors:  W Klapper; H Stoecklein; S Zeynalova; G Ott; F Kosari; A Rosenwald; M Loeffler; L Trümper; M Pfreundschuh; Reiner Siebert
Journal:  Leukemia       Date:  2008-08-28       Impact factor: 11.528

10.  Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event.

Authors:  Ken H Young; Qingmei Xie; Guimei Zhou; Jens C Eickhoff; Warren G Sanger; Patricia Aoun; Wing C Chan
Journal:  Am J Clin Pathol       Date:  2008-01       Impact factor: 2.493

View more
  10 in total

1.  C-MYC overexpression predicts aggressive transformation and a poor outcome in mucosa-associated lymphoid tissue lymphomas.

Authors:  Wenting Huang; Lei Guo; Hongyan Liu; Bo Zheng; Jianming Ying; Ning Lv
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges.

Authors:  Laura Moench; Zohar Sachs; Garth Aasen; Michelle Dolan; Vanessa Dayton; Elizabeth L Courville
Journal:  Leuk Lymphoma       Date:  2016-02-18

3.  HIV-Associated "Double-Hit" Lymphoma of the Tonsil: A First Reported Case.

Authors:  Chad Hinkle; Gabriel S Makar; Joshua D Brody; Nadir Ahmad; Gord Guo Zhu
Journal:  Head Neck Pathol       Date:  2020-01-29

4.  The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma.

Authors:  A Esteve-Arenys; J G Valero; A Chamorro-Jorganes; D Gonzalez; V Rodriguez; I Dlouhy; I Salaverria; E Campo; D Colomer; A Martinez; G Rymkiewicz; P Pérez-Galán; A Lopez-Guillermo; G Roué
Journal:  Oncogene       Date:  2018-01-22       Impact factor: 9.867

5.  Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition.

Authors:  T K Moyo; C S Wilson; D J Moore; C M Eischen
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

Review 6.  Double-Hit Lymphoma (MYC and BCL6) with Involvement of Skull and Adnexal Lesions: A Case Report and a Review of the Literature.

Authors:  Hamza Minhas; Cherif Abdelmalek; Marium Khan; James E O'Donnell; Vladimir Gotlieb; Jen Chin Wang
Journal:  Am J Case Rep       Date:  2018-08-30

7.  Diagnosis of fusion genes using targeted RNA sequencing.

Authors:  Erin E Heyer; Ira W Deveson; Danson Wooi; Christina I Selinger; Ruth J Lyons; Vanessa M Hayes; Sandra A O'Toole; Mandy L Ballinger; Devinder Gill; David M Thomas; Tim R Mercer; James Blackburn
Journal:  Nat Commun       Date:  2019-03-27       Impact factor: 14.919

8.  Transformation of follicular lymphoma to double hit B-cell lymphoma causing hypercalcemia in a 69-year-old female: a case report and review of the literature.

Authors:  Sakshi Kapur; Miles B Levin
Journal:  Case Rep Hematol       Date:  2014-08-04

9.  Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements.

Authors:  Ellen D McPhail; Matthew J Maurer; William R Macon; Andrew L Feldman; Paul J Kurtin; Rhett P Ketterling; Rakhee Vaidya; James R Cerhan; Stephen M Ansell; Luis F Porrata; Grzegorz S Nowakowski; Thomas E Witzig; Thomas M Habermann
Journal:  Haematologica       Date:  2018-06-14       Impact factor: 9.941

10.  Clinicopathologic features and prognostic analysis of Waldeyer ring B-cell lymphoma.

Authors:  Zhiping Ma; Yi Shi; Xuelian Pang; Xinxia Li; Wenli Cui; Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.